Pain during second trimester induced abortion
Conditions
Interventions
Trade Name: Marcain
Product Name: Marcain
Pharmaceutical Form: Injection*
Sponsors
Department of Obstetrics and Gynaecology, Karolinska Institutet, Stockholm
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Women according to ultrasound dating of pregnancy are pregnant in 13 weeks or more and wish to have an induced abortion at Söder Hospital will be asked if they want to participate in the study. Women must be 18 years or older and able to communicate in Swedish. The woman will receive oral and written information about the study and provide signed consent for their participation. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Allergy to local anesthetics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Can the number of women who experience severe pain (VAS> 7) during induced abortion after 13 weeks of gestation, be reduced through the use of PCBs with Marcain ® as a method of pain relief during abortion?;Secondary Objective: • How can paracervical block (PCB) with Marcain affect the interval from induction to abortion during induced abortion after 13 weeks of gestation? •What is the woman´s experience of pain and pain treatment after induced abortion after 13 weeks of gestation? • Is vacuum aspiration or other complcations more frequent after PCB compared to women who not has got PCB during induced abortion after 13 weeks of gestation ? ;Primary end point(s): The woman´s experience of pain will be measured by a visual analogue scale (VAS) from 0 to 10. The primary end point is VAS7, as the peak value during the abortion (from induction to abortion) for every individual woman. | — |
Countries
Sweden
Outcome results
None listed